Arkolith/Insider Trading/TECH/Form 4

Kelderman Kim

Chief Executive Officer, DirectorBIO-TECHNE Corp (TECH) · full profile →Form 4 · filed Aug 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Tax withholding(F)4K$53.60$231K51K
Aug 15, 2025Option exercise(M)9K—$055K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 15, 2025Option exercise(M)9K—$017K
Aug 15, 2025Grant(A)71K—$071K
Aug 15, 2025Grant(A)90K—$090K
Aug 15, 2025Grant(A)35K—$035K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-014700) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML